Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com//news-release/2024/03/01/2838800/0/en/Chiesi-Global-Rare-Diseases-Launches-Rethink-Acromegaly-Campaign-to-Provide-Important-Disease-Education-and-Support-to-the-Acromegaly-Community.html
https://www.globenewswire.com//news-release/2024/02/05/2823523/0/en/Chiesi-Global-Rare-Diseases-Announces-Health-Canada-Approval-of-MYALEPTA-metreleptin-for-injection-for-the-Treatment-of-Patients-with-Lipodystrophy.html
https://www.prnewswire.com/news-releases/pantherx-rare-selected-by-chiesi-global-rare-diseases-for-the-distribution-of-filsuvez-birch-triterpenes-topical-gel-302053510.html
https://www.prnewswire.com/news-releases/chiesi-global-rare-diseases-announces-publication-of-results-from-phase-3-balance-study-in-fabry-disease-302031531.html
https://www.globenewswire.com//news-release/2023/12/19/2798751/0/en/Chiesi-Global-Rare-Diseases-Receives-FDA-Approval-for-FILSUVEZ-birch-triterpenes-topical-gel-for-the-Treatment-of-Epidermolysis-Bullosa.html
https://www.prnewswire.com/news-releases/chiesi-global-rare-diseases-announces-multiple-presentations-at-ssiem-annual-symposium-2023-301916250.html
https://www.prnewswire.com/news-releases/chiesi-global-rare-diseases-and-protalix-biotherapeutics-announce-fda-approval-of-elfabrio-pegunigalsidase-alfa-iwxj-for-the-treatment-of-fabry-disease-301820680.html